Triderm | Triamcinolone Acetonide Cream Breastfeeding
It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Triderm | Triamcinolone Acetonide Cream is safe for baby while breastfed.

What is Triderm | Triamcinolone Acetonide Cream used for?


Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

What are the risk associated with Triderm | Triamcinolone Acetonide Cream usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Triderm | Triamcinolone Acetonide Cream low risk for breastfeeding
Triderm | Triamcinolone Acetonide Cream contains only one active ingredient that is Triamcinolone acetonide. We have analyzed the usage of Triamcinolone acetonide in breastfeeding and our analysis suggest that Triamcinolone acetonide poses Low risk for infant while breastfeeding and hence Triderm | Triamcinolone Acetonide Cream itself shall be considered Low risk item for breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have a deleterious effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.

Triderm | Triamcinolone Acetonide Cream Breastfeeding Analsys


Triamcinolone acetonide while Breastfeeding

Low Risk

CAS Number: 76-25-5

Triderm | Triamcinolone Acetonide Cream and breastfeeding

A corticosteroid with a mainly glucocorticoid action and anti-inflammatory effects of similar strength to that of prednisolone.Systemic administration (oral, injection), inhaled (bronchial, nasal), intra-articular, intravitreous and topical.Indicated in the treatment of rheumatic diseases and collagen, inflammatory bowel disease, dermatitis, asthma, rhinitis, etc. This comment is about systemic, intra-articular and ophthalmic triamcinolone. Since the last update we have not found published data about its excretion in breast milk. Administration of intra-articular triamcinolone in the wrist (Smuin 2016) or via an epidural in the cervical area (McGuire 2012) caused a temporary decrease in the production of milk lasting between one and four weeks that was resolved in both cases via the continuation and stimulation of breastfeeding. The same has occurred, with a shorter duration, following the intra-articular administration of methylprednisolone (Babwah 2013). Although after the administration of triamcinolone, both intraocular (Shen 2010, Degenring 2004), and epidural (Hooten 2016), elimination half-life is about 22-25 days, plasma levels are indetectable or very low, not clinically significant. The maximum concentration peak after these types of administration occurs at 24 hours (Hooten 2016, Shen 2010, Degenring 2004). There is consensus among experts that, in general, neither systemic corticoids nor inhaled ones present a breastfeeding contraindication (National Asthma Education 2004). The low plasma levels obtained after ophthalmic administration suggest a very low risk during breastfeeding. Corticoids are of commonally used in pediatrics and have no side effects when they are used in isolation or in short-term treatments. Until there is more published data about this drug in relation to breastfeeding, alternatives with a safer known pharmacokinetic profile for breastfeeding may be preferable (greater protein binding, lesser half-life and less oral bioavailability), especially during the neonatal period and in case of prematurity. If used during breastfeeding it is advisable to monitor milk production. See below the information of these related products:


Is Triderm | Triamcinolone Acetonide Cream safe while breastfeeding

What should I do if already breastfed my kid after using Triderm | Triamcinolone Acetonide Cream?

Triderm | Triamcinolone Acetonide Cream is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Triderm | Triamcinolone Acetonide Cream so you should inform him based on your convenience.


I am nursing mother and my doctor has suggested me to use Triderm | Triamcinolone Acetonide Cream, is it safe?

Though Triderm | Triamcinolone Acetonide Cream dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Triderm | Triamcinolone Acetonide Cream, will my baby need extra monitoring?

Not much monitoring required while using Triderm | Triamcinolone Acetonide Cream


Who can I talk to if I have questions about usage of Triderm | Triamcinolone Acetonide Cream in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week